ALPMY

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

About ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. (ALPMY)

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.

Details

Daily high

$9.38

Daily low

$8.98

Price at open

$9.22

52 Week High

$13.14

52 Week Low

$8.37

Market cap

16.7B

Dividend yield

1.01%

Volume

169,535

Avg. volume

293,523

P/E ratio

-43.73

ASTELLAS PHARMA UNSP/ADR by Astellas Pharma, Inc. News